0.3425
price up icon2.76%   0.0092
 
loading
前日終値:
$0.3333
開ける:
$0.3339
24時間の取引高:
125.56K
Relative Volume:
0.31
時価総額:
$22.27M
収益:
$1.22M
当期純損益:
$-14.15M
株価収益率:
-1.631
EPS:
-0.21
ネットキャッシュフロー:
$-6.55M
1週間 パフォーマンス:
-4.25%
1か月 パフォーマンス:
-14.35%
6か月 パフォーマンス:
-33.22%
1年 パフォーマンス:
+11.93%
1日の値動き範囲:
Value
$0.3302
$0.3486
1週間の範囲:
Value
$0.33
$0.3606
52週間の値動き範囲:
Value
$0.2501
$0.9099

IGC Pharma Inc Stock (IGC) Company Profile

Name
名前
IGC Pharma Inc
Name
セクター
Healthcare (1195)
Name
電話
301-983-0998
Name
住所
4336 Montgomery Avenue, Bethesda, MD
Name
職員
16
Name
Twitter
@IGCIR
Name
次回の収益日
2024-11-07
Name
最新のSEC提出書
Name
IGC's Discussions on Twitter

IGC を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
IGC 0.3425 22.27M 1.22M -14.15M -6.55M -0.21
VRTX 449.74 115.43B 10.63B -479.80M -1.35B 13.33
REGN 749.06 82.04B 13.85B 4.65B 3.32B 35.06
ARGX 589.18 35.30B 1.86B -40.29M -1.28B -4.16
ALNY 248.25 32.04B 2.09B -332.26M 16.06M -4.14
BNTX 106.30 24.89B 3.30B -501.07M 1.03B 11.54

IGC Pharma Inc (IGC) 最新ニュース

pulisher
Nov 15, 2024

IGC Pharma Reports Second Quarter Fiscal 2025 Results, Showcasing Progress in Its Alzheimer’s Pipeline - WSIL TV

Nov 15, 2024
pulisher
Nov 14, 2024

IGC Pharma Reports 42% Revenue Growth, Advances Multiple Alzheimer's Drug Candidates | IGC Stock News - StockTitan

Nov 14, 2024
pulisher
Nov 14, 2024

IGC (IGC Pharma) Price-to-Operating-Cash-Flow : (As of Nov. 14, 2024) - GuruFocus.com

Nov 14, 2024
pulisher
Nov 06, 2024

IGC Pharma Announces Publication of IMS Spotlight Interview Highlighting Strategic Expansion in Alzheimer’s and Weight Loss Therapies - AccessWire

Nov 06, 2024
pulisher
Nov 06, 2024

IGC Pharma CEO Reveals AI-Driven Strategy in Alzheimer's and Weight Loss Drug Development | IGC Stock News - StockTitan

Nov 06, 2024
pulisher
Nov 03, 2024

IGC Pharma (STU:IGS1) Asset Turnover : 0.03 (As of Jun. 2024) - GuruFocus.com

Nov 03, 2024
pulisher
Oct 17, 2024

MD’s IGC Pharma enrolls patients in Phase 2 trial for Alzheimer’s dementia drug - Maryland Daily Record

Oct 17, 2024
pulisher
Oct 17, 2024

IGC Pharma Announces Patient Enrollment at Toronto's Baycrest in Phase 2 Trial Investigating IGC-AD1 - AccessWire

Oct 17, 2024
pulisher
Oct 13, 2024

Coya Therapeutics Has Several Near-Term Share Price Appreciation Catalysts - Seeking Alpha

Oct 13, 2024
pulisher
Oct 08, 2024

A Guide To The Risks Of Investing In IGC Pharma Inc (IGC) - Knox Daily

Oct 08, 2024
pulisher
Oct 08, 2024

Investor’s Delight: IGC Pharma Inc (IGC) Closes Strong at 0.37, Up 0.13 - The Dwinnex

Oct 08, 2024
pulisher
Oct 08, 2024

Was IGC Pharma Inc (IGC)’s session last reading good? - US Post News

Oct 08, 2024
pulisher
Oct 05, 2024

BioMedNewsBreaks — IGC Pharma Inc. (NYSE American: IGC) Announces Stockholders’ Approval of All Disclosed Proposals at 2024 Annual Meeting - MSN

Oct 05, 2024
pulisher
Oct 03, 2024

IGC Pharma Wins 2 Prizes in Phase 1 of National Institutes of Health's AI PREPARE Challenge - Markets Insider

Oct 03, 2024
pulisher
Oct 03, 2024

Financial Metrics Check: IGC Pharma Inc (IGC)’s Ratios for Trailing Twelve Months - The Dwinnex

Oct 03, 2024
pulisher
Oct 01, 2024

A Look at IGC Pharma Inc (IGC) Shares in the Recent Past Indicates Growth - SETE News

Oct 01, 2024
pulisher
Sep 30, 2024

IGC Pharma Inc’s latest rating changes from various analysts - Knox Daily

Sep 30, 2024
pulisher
Sep 30, 2024

IGC’s Stock Market Pendulum: Swinging Between Gains and Losses - The InvestChronicle

Sep 30, 2024
pulisher
Sep 30, 2024

Is IGC Pharma Inc (AMEX:IGC) stock a better investment at this time? - US Post News

Sep 30, 2024
pulisher
Sep 30, 2024

AvePoint Inc’s latest rating changes from various analysts - Knox Daily

Sep 30, 2024
pulisher
Sep 30, 2024

IGC Pharma Inc (AMEX: IGC) Down -0.99% This Year: What Is Going To Happen Next - Stocks Register

Sep 30, 2024
pulisher
Sep 27, 2024

IGC Pharma director James Moran buys $200k in company stock - Investing.com Australia

Sep 27, 2024
pulisher
Sep 27, 2024

IGC Pharma director James Moran buys $200k in company stock By Investing.com - Investing.com South Africa

Sep 27, 2024
pulisher
Sep 24, 2024

Ipca Labs shares hit lifetime high after Nomura raises target price - Business Standard

Sep 24, 2024
pulisher
Sep 24, 2024

IPCA Labs shares hit fresh 52-week high as Nomura upgrades target price on strong growth plans - Moneycontrol

Sep 24, 2024
pulisher
Sep 24, 2024

Ipca Labs Shares Hit Life High As Nomura Hikes Target Price - NDTV Profit

Sep 24, 2024
pulisher
Sep 23, 2024

Nomura expects IPCA Labs shares to rally over 20% from current price, retains Buy call - Business Upturn

Sep 23, 2024
pulisher
Sep 23, 2024

EC approves Iqirvo plus UDCA to treat primary biliary cholangitis - World Pharmaceutical Frontiers

Sep 23, 2024
pulisher
Sep 23, 2024

IPCA Laboratories Looking to Consolidate US Generics Business; Shares Gain - EquityPandit

Sep 23, 2024
pulisher
Sep 23, 2024

Ipca Laboratories to Consolidate US Generics Business; Shares Up 1% - Indiainfoline

Sep 23, 2024
pulisher
Sep 23, 2024

Ipca Laboratories to consider consolidaton of US generics business - CNBCTV18

Sep 23, 2024
pulisher
Sep 21, 2024

StockNews.com Upgrades ICL Group (NYSE:ICL) to Strong-Buy - MarketBeat

Sep 21, 2024
pulisher
Sep 21, 2024

Ipsen’s Iqirvo approved in Europe - The Pharma Letter

Sep 21, 2024
pulisher
Sep 20, 2024

ICL Group (NYSE:ICL) Hits New 12-Month Low at $3.80 - MarketBeat

Sep 20, 2024
pulisher
Sep 20, 2024

Ipsen’s Iqirvo® (elafibranor) approved in the European - GlobeNewswire

Sep 20, 2024
pulisher
Sep 19, 2024

Ratio Revelations: IGC Pharma Inc (IGC)’s Financial Metrics in the Spotlight - The Dwinnex

Sep 19, 2024
pulisher
Sep 19, 2024

IGC-AD1 shows promise in Alzheimer's tau pathology treatment By Investing.com - Investing.com Canada

Sep 19, 2024
pulisher
Sep 19, 2024

Short Interest in ICL Group Ltd (NYSE:ICL) Declines By 6.3% - MarketBeat

Sep 19, 2024
pulisher
Sep 19, 2024

IGM Biosciences (NASDAQ:IGMS) Trading Down 4.1% on Insider Selling - Defense World

Sep 19, 2024
pulisher
Sep 18, 2024

ICL Group (NYSE:ICL) Shares Gap Down to $4.19 - Defense World

Sep 18, 2024
pulisher
Sep 18, 2024

IGC-AD1 shows promise in Alzheimer's tau pathology treatment - Investing.com

Sep 18, 2024
pulisher
Sep 18, 2024

IGC Pharma Announces Additional Data Supporting IGC-AD1 as an Alzheimer's Treatment - Business Wire

Sep 18, 2024
pulisher
Sep 04, 2024

The Daily Hit: September 4, 2024 - Green Market Report

Sep 04, 2024
pulisher
Sep 04, 2024

IGC Pharma targets Alzheimer’s market with anti-amyloid drug candidate - Green Market Report

Sep 04, 2024
pulisher
Sep 04, 2024

IGC Pharma Advances IGC-AD1 Toward Clinical Trials as a Potential anti-Amyloid Plaque Treatment for Alzheimer's Disease - Yahoo Finance

Sep 04, 2024
pulisher
Sep 04, 2024

IGC Pharma (NYSEMKT:IGC) Given New $3.75 Price Target at Ascendiant Capital Markets - Defense World

Sep 04, 2024
pulisher
Sep 04, 2024

FTC Solar, Inc. (NASDAQ:FTCI) Given Average Rating of “Moderate Buy” by Brokerages - Defense World

Sep 04, 2024
pulisher
Sep 03, 2024

The Analyst Verdict: IGC Pharma In The Eyes Of 4 Experts - Benzinga

Sep 03, 2024
pulisher
Sep 03, 2024

Moderna, Amgen, Other Pharma Stocks Have Clinical Trials That Could Send Them Soaring - Barron's

Sep 03, 2024
pulisher
Aug 27, 2024

The 7 Best Stocks Under 50 Cents To Buy For October 2024! - The Stock Dork

Aug 27, 2024
pulisher
Aug 26, 2024

IGC Announces Results of its 2024 Annual Stockholders Meeting - Business Wire

Aug 26, 2024

IGC Pharma Inc (IGC) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
$18.98
price up icon 1.80%
$70.68
price down icon 0.42%
$38.38
price up icon 3.49%
$369.83
price up icon 1.48%
$196.58
price up icon 0.88%
$102.64
price up icon 0.27%
大文字化:     |  ボリューム (24 時間):